(Q34202477)

31 July 2017

1 reference

title

Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. (English)

1 reference

31 July 2017

0 references

H E Elphick

1

1 reference

PubMed ID

11279745

31 July 2017

A Tan

series ordinal

2

1 reference

31 July 2017

1 January 2001

1 reference

Cochrane Database of Systematic Reviews

31 July 2017

1 reference

31 July 2017

1

1 reference

31 July 2017

CD002007

1 reference

Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis

31 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Treatment of pulmonary infections in patients with cystic fibrosis: A comparative study of ticarcillin and gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Immediate and prolonged clinical efficacy of ceftazidime versus ceftazidime plus tobramycin in chronic Pseudomonas aeruginosa infection in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Comparison of cefoperazone sodium vs methicillin, ticarcillin, and tobramycin in treatment of pulmonary exacerbations in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

An in vivo assessment of the tobramycin/ticarcillin interaction in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Current understanding of the inflammatory process in cystic fibrosis: onset and etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Antimicrobial resistance: bacteria on the defence. Resistance stems from misguided efforts to try to sterilise our environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Aminoglycoside induced ototoxicity in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

Systematic reviews and lifelong diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002007

10.1002/14651858.CD002007

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11279745